This research reports a novel strategy for enhancing optical sensing with liquid crystal biosensors, indicating significant practical applications.
Liquid crystal (LC)-based biosensors are attractive for translating subtle molecular interactions into optical signals, but their practical application is hindered by inherent fragility and limited LC regulation principles. Here, we report a universal strategy to construct robust and customizable sensing platforms by integrating nematic LCs into inorganic inverse opals (IO). This approach represents a paradigm shift from using substrates as passive supports to actively engineering them as regulators of the LC orientation. The resulting LC-infiltrated photonic crystal composites exhibit precisely tunable macroscopic optical responses governed by substrate-guided LC reorientation. Using IO-TiO₂ as a model, we establish a unique LC regulation mechanism by exploiting its structural and chemical properties. This mechanism was further elucidated through multiscale computational and experimental investigations. As a proof-of-concept, a one-step and reliable biosensor for reflective spectral detection of tetracycline (a common antibiotic pollutant) is constructed, achieving a linear range of 1 nM to 50 μM and a detection limit of 0.10 nM. Notably, the IO-TiO₂ substrate contributes to enhanced sensor durability and regenerability, evidenced by consistent performance over eight regeneration cycles (relative standard deviation, RSD = 3.06%). These results validate the practical potential of this biosensor, thereby confirming the design flexibility and broad applicability of our strategy. Overall, the integration offers a promising pathway for designing robust LC-responsive systems, with significant potential for advancing compact and customized optoelectronic sensors.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: